Article Versions Notes

Matheux A, Gassiot M, Fromont G, Leenhardt F, Boulahtouf A, Fabbrizio E, Marchive C, Garcin A, Agherbi H, Combès E, et al. PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1. Cancers. 2021; 13(14):3635. https://doi.org/10.3390/cancers13143635

Matheux, Alice, Matthieu Gassiot, Gaëlle Fromont, Fanny Leenhardt, Abdelhay Boulahtouf, Eric Fabbrizio, Candice Marchive, Aurélie Garcin, Hanane Agherbi, Eve Combès, and et al. 2021. "PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1" Cancers 13, no. 14: 3635. https://doi.org/10.3390/cancers13143635

Matheux, A., Gassiot, M., Fromont, G., Leenhardt, F., Boulahtouf, A., Fabbrizio, E., Marchive, C., Garcin, A., Agherbi, H., Combès, E., Evrard, A., Houédé, N., Balaguer, P., Gongora, C., Mbatchi, L. C., & Pourquier, P. (2021). PXR Modulates the Prostate Cancer Cell Response to Afatinib by Regulating the Expression of the Monocarboxylate Transporter SLC16A1. Cancers, 13(14), 3635. https://doi.org/10.3390/cancers13143635